Get access to our best features
Get Started
Subscribe
Israeli-Palestinian Conflict
Baseball
2024 US Election
Donald Trump
Joe Biden
Earth Day
US Politics
US Social Issues
US Crime
US Economy
Golf
Republican Party
Marijuana
Get access to our best features
Get Started
Published 1 year ago

Cell and Gene Therapy Manufacturing Costs Limiting Access

Summary by Ground News
High production costs are limiting patient access to cell and gene therapies. Researchers say optimizing manufacturing methods and increasing capacity industry-wide would help. Analysis by the Institute for Clinical and Economic Review (ICER) suggests the average cost of a gene therapy is between $1 million and $2 million per dose.

0 Articles

All
Left
Center
Right
GEN - Genetic Engineering and Biotechnology News…GEN - Genetic Engineering and Biotechnology News…

Cell and Gene Therapy Manufacturing Costs Limiting Access

The cell and gene therapy industry needs support to increase production capacity.

1 year ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal